Antimycobacterials Flashcards
Isoniazid
First Line Antimycobacterial Agent (TB)
MOA:
- Prodrug activated by bacterial enzymes (katG)
- Inhibits synthesis of mycolic acids
–> Preventing mycobacterium cell wall formation
AE:
- Hemolytic anemia (In people with glucose-6-phosphate dehydrogenase deficiency)
Rifampicin
First Line Antimycobacterial Agent (TB and Leprosy)
Characteristic:
- Only works on prokaryotic cells
MOA:
- Binds to and inhibits DNA-dependent RNA polymerase
–> Prevents translation of mRNA into proteins
AE:
- Acute interstitial nephritis (rare)
- Orange tinge to saliva, tears, sweat
TB & Leprosy
Ethambutol
First Line Antimycobacterial Agent (TB)
Characteristics:
- Only works on mycobacteria
MOA:
- Inhibits arabinosyl transferase
–> Impairs mycobacterial cell wall synthesis
AE:
- Optic neuritis (Red-green colour blindess)
- Peripheral neuropathy
–> Should not be given to those younger than 5 as it is hard to monitor these AE
Pyrazinamide
First Line Antimycobacterial Agent (TB)
Characteristics:
- Nicotinamide analog
- Prodrug for Pyrazinoic acid
- Tuberculostearic at acidic pH
MOA:
- Inhibits fatty acid synthase
–> Prevents fatty acid synthesis
AE:
- Gout
- Hepatic Damage
Capreomycin
Second Line Antimycobacterial Agent (TB)
Characteristics:
- Peptide antibiotic
MOA:
- Binds 70S ribosomal subunit
–> inhibits protein synthesis
AE:
- Kidney damage
- Auditory nerve damage (Deafness and ataxia)
- Contraindicated with Streptomycin
Cycloserine
Second Line Antimycobacterial Agent (TB)
Characteristics:
- Broad spectrum antibiotic
MOA:
- Prevent formation of tripeptide side chains of N-acetylmuramic acid
–> Important building block for peptidoglycan
–> Inhibits bacterial cell wall
Streoptomycin
Second Line Antimycobacterial Agent (TB)
MOA:
- Binds irreversibly to 30S subunit to inhibit protein synthesis
Bedaquiline
Multi drug resistant TB Agent
Characteristic:
- First-in-class Diarylquinoline agent
MOA:
- Inhibits ATP synthase in mycobacteria
Delamanid
Multi drug resistant TB Agent
Characteristic:
- Cell wall active nitro-dihydroimidazooxazoles
- Prodrug activated by mycobacterial nitroreductase
MOA:
- Inhibits synthesis of mycolic acids
Dapsone
Antimycobacterial Agent (Leprosy)
Characteristics:
- Related to sulfonamides
MOA:
- Inhibits bacterial folate synthesis
AE:
- Hemolysis of RBC
- Methemoglobinemia,
- Lepra Reactions (Can worsen inflammation)
Clofazimine
Antimycobacterial Agent (Leprosy)
Characteristics:
- A dye with proposed action against leprosy bacilli
MOA:
- Involves action on DNA
- May be anti-inflammatory
AE:
- Reddish colour of skin and urine
TB Therapy
Initial (2 months)
- Isoniazid, Rifampicin, and Pyrazinamide (possibly Ethambutol)
Continuation (4 months)
- Isoniazid and Rifampicin
Leprosy Therapy
Tuberculoid Leprosy (6 months)
- Dapsone, Rifampicin
(Fewer skin lesions)
Lepromatous Leprosy (2 years)
- Dapsone, Rifampicin, Clofazimine
(Wide spread skin lesions)